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Premature rupture of the membranes - further results
with the use of PVP-iodine for prevention of aäcending
infection and clinical management
E.Saling, B. Weßmann, Berlin
The permanent Infusion of highly diluted PVP-iodine so-
lution into the vagina in cases of premature rupture of
membranes has been introduced three years ago in German
( 1 ) and two years ago in English (2) literature*
Results
For this panel we prepared a new evaluation, concerning
the most important clinical success criteria, prefer-
ably the infant morbidity and mortality caused by in-
fection (Tab. 1 ) . During the period from January 1977
to December 198O,
161 premature in-
fant s ( <37/O weäcs
of gestation) born
after a latency
period of more than
18 hours after pre-
mature rupture of
membranes and va-
ginal PVP-iodine
prophylaxis, no
infant died in the
whole neonatal pe-
riod (Ist to 28th
Comparison of morbidity and mortality of premature infants ( < 37/0 pregnancy weeks,
birthweight > 1000 g) in the newborn period (1-28 day of life) after early rupture of
the membranes (latency: rupture-birth > 18 hours).
Clinical procedure
No vaginal
infection
prophylaxis
With vaginal
PVP-iodine-
infusion
Latency: rupture
of the membranes-
infus.:<4 hours
Latency: rupture
of the membranes-
infus.: > 4 hours
All cases with
PVP-iodine-
infusion
Period
V 1/74
-XI 1/76
1/77-
XU/80
No.of
cases
n=77
n=126
n=35
n=161
Morbidity
severe
nfections
n %
8
S9H
5
···7
12
10.4
sas
•BS9BB
4.0
··20.0
7.5
Mort
caus
severe
infections
n %
5
··
0
«··0
0
6.5
···
0
—ea0
0
ality
ed by
other
reasons
n %
2
1
2
3
2.6
0.8
5.7
1.9
Total
mortality
n %
7
1
2
3
9.1
0.8
5.7
1.9
day of life). The
Tab. 1 mortality during
the period before
the application of PVP-iodine lay in the region of 6 .5%
in our department; related to our present material of
161 cases, this would be 1O or 11 infants.
Average gestational age, birthweight and the 10th, 50th and 90th
percentile for the latency period between rupture of membranes
and birth.
Without PVP-iodine-
prophylaxis
VI/74-XII/76
PVP-iodine-
prophylaxis
I/77-XII/80
Gestational
age
x=33/3 + 3/0
x=33/6 ± 3/0
Birthweight
x= 2220±590
x=2250±540
Latency period (hours)
10. 50. 90.
percentile
23
23
52
65
167
193
Tab. 2
A direct statisti-
cal comparison of
the two groups can-
not be given in
füll äs they were
taken from differ-
ent periods. How-
ever the results
are nevertheless
very informative
äs, in the previous
period before app-
lication of PVP-
iodine, we tended
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to a more active management, which would rather reduce
infection morbidity and mortality. The more active ma-
nagement is reflected through the shorter latency
period between premature rupture of membranes and the
birth (Tab. 2 ) .
When considering infant morbidity caused by infection
it is shown (Tab. 1) that this is only less in the
group of 126 infants which received the PVP-iodine app-
lication within 4 hours after rupture of the membranes
out of the total of 161 who received PVP-iodine treat-
ment at all.
In the remaining group of 35 infants where the PVP-
iodine application was not started within 4 hours after
rupture the morbidity was higher, twice äs high äs in
the period before the use of PVP-iodine, but fortunate-
ly none of the.se infants died from severe infection du-
ring the neonatal period. In any case it's recommend-
able to achieve the shortest possible latency period
between rupture of membranes and PVP-iodine application.
Side effects of iodine-resorption
After premature rupture of the membranes and PVP-iodine
prophylaxis, the fetus is very probably not directly
exposed to the PVP-iodine solution. However vaginal
iodine-resorption can occur through the mother, which
can lead to an iodine increase in the fetal blood and
can interfere with the thyroid function of the newborn.
In order to elucidate whether we are dealing with a
harmful and lasting or a transient and tolerable effect,
the TSH and thyroid hormone concentrations of these new-
born and of all newborn whose mothers received PVP-
iodine infection prophylaxis during intensive monitoring
throughout the labor - altogether 1045 infants - have
been investigated (Tab. 3 ) . This is a cooperative study
with the Department
of Pediatrics of the
Free University.of
Berlin. We found in
1O4 cases elevated
TSH-values of more
than 20 ;iU/ml, and
in 13 cases of more
than 50 pU/ml. These
newborn have been
contfolled until
normalization. We
Prospective study of newborn treated with PVP-iodine after premature
rupture of membranes and sub partu.
D. l'Allemand , A. Grüters, B. Weßmann, H. Helge, E. Saling
Period of
time
July 1978-
April 1979
and
Nov. 1980-
July 1981
Time of
TOU
determi-
nation
UAB,
3rdor
5th day
Number
1045
. Elevated TSH-values U/ml
>20
104= 10.0%
> 50
13 = 1.2%
TSH-control
on 10th day
normal
UAB = Umbilical artery blood
Tab. 3
were reassured to find that the striking alterations of
TSH and thyroid hormones did not last longer than 10
days.
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As far äs such a transient depression of thyroid activi-
ty is not taken äs an indication for substitutdve thera-
py by pediatric endocrinologists, we can accept the Si-
tuation when careful control and follow up examinations
are guaranteed.
However, these TSR elevations may Imitate changes found
in congenital hypothyroidism, and thereby cause anxiety
in parents and the responsible doctor.
Therefore, close cooperation between the obstetrician
using £>VP-iodine and the screening laboratory is impor-
tant, in order to avoid unnecessary diagriostic and the-
rapeutic procedures in these infants ön the one hand,
and on the other hand not to miss an early treatment of
true congenital hyp o thyroid i situ
Due to the possibility of iodine resorption occurririg
•through the mother, all pregnant women should be exclu-
ded from this therapy who have had thyroid illness in
the past.
If in the future other suitable disinfectant Solutions
without any negative side-effects could be foünd f then
it could be recommendable to renounce on the üse of
Solutions containing iodine.
At the present time we use the following clinical proce-
dure in cases of eairly rupture of membranes: a) Using
PVP-iodine prophylaxis, if necessary bombined with toco-
lytic::therapy (application of betamimetics)
 f we wait
when possible until the pregnancy has reached 35 comple-
ted weeks. Up to this point the fetus has grown suffi-
ciently not to be particularly endangered äs it is close
to ternu Also the chances are much better for the new-
born not to be separated too long from his möther if at
all. b) At the very beginning of our management we give
- if the gestational age is 26 weeks - lung maturation
treatment consisting of four doses of 4 mg Betamethason
every 12 hours. c) From the 36th week of gestation on-
wards we discontinue the tocolytic therapy and wait some
hours until spontaneous labor Starts. If this is not
the case and cervix ripeness is given (Bishop Score >7 f
better >8) , we induce labor by oxytocin infusion. We
Start with O.5 mU and increase the dose every 5 minutes
by O.5 mU respectively. If cervix ripeness is insuffi-
cient we apply PG-Gel (O.4 mg = 40 g PGEp) into the
cervix and wait until a sufficient ripeness is achieved
and then induce labor actively.
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